drugset
drugset / Trial / NCT01984541

To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.

NCT01984541 ↗

Phase 2 Completed 30 enrolled Laboratorios Leti, S.L.
NaSingle-groupOpen-labelDiagnostic

Summary

The objective of this study is to determine the biological activity of Artemisia vulgaris allergen extract in histamine equivalent units (HEP) units, in order to be used as in-house reference preparation (IHRP).

Timeline

Start
2014-03
Primary completion
2014-06
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemisia vulgaris Unknown 0.01 mg/ml —
Subject Artemisia vulgaris Unknown 0.1 mg/ml —
Subject Artemisia vulgaris Unknown 1 mg/ml —
Subject Artemisia vulgaris Unknown 10 mg/ml —

Indications

allergic respiratory disease